Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclic nucleotide-gated cation channel beta 3 (CNGB3) is a protein subunit that forms part of the cone photoreceptor cyclic nucleotide-gated (CNG) channels. These channels are essential for visual signal transduction in response to light. CNGB3 contributes unique structural features influencing ion permeation. Its primary role is mediating photoresponses under bright light conditions. Mutations in CNGB3 cause autosomal recessive achromatopsia, characterized by loss of color discrimination, highlighting its critical role in human cone cells for daylight/color vision.
Direct gating by cyclic nucleotides leading to ion channel opening and depolarization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic nucleotide-gated cation channel beta 3.